Author: Berkeley Lovelace Jr.

The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.

Democrats’ victories in the midterm elections could impact healthcare, from how much people pay for health insurance and prescription drugs to what coverage is available.

Courtney Mroch was already paying a high price for health insurance when she learned her insurer, Cigna, was pulling out of Tennessee’s Affordable Care Act marketplace.

The Department of Health and Human Services is giving compounding pharmacies a temporary green light to make six peptides while the agency continues to work on a formal rule change.

A federal judge in Louisiana ordered the agency to provide an update on its safety study as part of a lawsuit seeking to overturn a provision allowing mifepristone to be delivered by mail.

Ahead of the Nov. 3 midterm elections, President Donald Trump has increasingly touted his drug pricing deals, claiming the U.S. is now paying the world’s lowest prescription drug prices.

The death of a 28-year-old woman who worked in an anti-plague laboratory in Russia is raising concerns about what caused her illness.

Participants who took the experimental drug retatrutide experienced the largest weight loss ever seen in a drug trial for diabetes.

Dr. Heidi Overton, a fierce opponent of abortion rights, declined to say whether she personally believes the abortion pill mifepristone is safe.

The Trump administration is removing hundreds of thousands of enrollees from Obamacare plans, claiming that many were receiving subsidies they didn’t qualify for and that some did not even exist.

People looking to get their annual flu shot this fall may find a new option alongside the usual vaccines: an mRNA flu shot. Not everyone is eligible, however.

Most Americans can expect to pay significantly more each month for health insurance next year, whether they get it through work, the Affordable Care Act or Medicare.